Allspring Global Investments Holdings, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1890906
CHARLOTTE, NC
Position in VRTX
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$55,263,790
-$141,334 QoQ
Shares Held
123,760
+1.3% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
17 quarters on record
Voting authority
Sole 11.027795733678087.ToString("F0")%
Shared 0.ToString("F0")%
None 88.97220426632191.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Allspring Global Investments Holdings, LLC holds $702,720,315 across 64 Biotechnology names. VRTX ranks #5 (7.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
175,311 | $128,020,857 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
281,793 | $93,236,848 | |
| 3 | EXEL |
Exelixis, Inc.
|
1,707,715 | $73,243,895 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
889,356 | $66,043,575 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
123,760 | $55,263,790 | |
| 6 | INSM |
INSMED Inc
|
282,734 | $46,232,662 | |
| 7 | ASND |
Ascendis Pharma A/S
|
184,224 | $42,137,554 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
52,497 | $40,561,281 |
All Filings in VRTX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $55,263,790 | 123,760 | Shares | Other | 2026-05-05 | |
| 2025-12-31 | $55,405,124 | 122,210 | Shares | Other | 2026-01-15 | |
| 2025-09-30 | $49,684,624 | 126,863 | Shares | Other | 2025-10-20 | |
| 2025-06-30 | $56,335,606 | 126,540 | Shares | Other | 2025-07-25 | |
| 2025-03-31 | $52,617,029 | 108,529 | Shares | Other | 2025-04-24 | |
| 2024-12-31 | $38,911,290 | 96,626 | Shares | Defined | 2025-01-29 | |
| 2024-09-30 | $109,910,495 | 236,326 | Shares | Defined | 2024-10-18 | |
| 2024-06-30 | $93,241,063 | 198,927 | Shares | Defined | 2024-07-26 | |
| 2024-03-31 | $96,750,922 | 231,456 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $86,807,132 | 213,343 | Shares | Defined | 2024-01-25 | |
| 2023-09-30 | $83,824,117 | 241,054 | Shares | Defined | 2023-10-27 | |
| 2023-03-31 | $128,316,352 | 407,263 | Shares | Defined | 2023-04-13 | |
| 2022-12-31 | $130,693,164 | 452,570 | Shares | Defined | 2023-01-23 | |
| 2022-09-30 | $138,168,777 | 477,201 | Shares | Defined | 2022-10-26 | |
| 2022-06-30 | $107,459,207 | 381,345 | Shares | Defined | 2022-07-25 | |
| 2022-03-31 | $87,582,836 | 335,605 | Shares | Defined | 2022-04-27 | |
| 2021-12-31 | $73,698,858 | 335,605 | Shares | Defined | 2022-01-28 | |
| No filing history on record for this holder in this stock. | ||||||